50% off Premium Yearly
Goldman SachsGSBUY ON WEAKNESSOct 09, 2026Stock price when the opinion was issued
As of Oct 09, 2026. Market Open.
Different businesses. LLY is a big play in GLP-1 drugs. How will pills effect the injections business? LLY has done a good job of navigating these new pills. GS enjoys increased stock market and IPO businesses. He prefers LLY, which is tied to a secular growth trend, but GS' good times in capturing revenue in this cycle will end.
Mergers are increasing, and banks like GS makes advisory fees from them. Also, the banks have been rallying since oil slumped, and will benefit further from rising interest rates, which appears will happen later this year. Plus, hyperscalers may need to keep borrowing money to keep competing with each other.
They report Tuesday. The banks have been some of the worst performers lately and are priced for disappointment. There's more to GS than IPOs and M&A. There's bond issuance and trading where the high volatility helps the bank's bottom line.